ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2008;85:978-981. doi:10.1016/j.athoracsur.2007.12.067
© 2008 The Society of Thoracic Surgeons

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Atli Eyjolfsson
Per Johnsson
Henrik Jönsson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eyjolfsson, A.
Right arrow Articles by Jönsson, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eyjolfsson, A.
Right arrow Articles by Jönsson, H.
Related Collections
Right arrow Extracorporeal circulation


Original Articles: Cardiovascular

Characterization of Lipid Particles in Shed Mediastinal Blood

Atli Eyjolfsson, MDa, Sara Sciclunaa, Per Johnsson, MD, PhDa, Filip Petersson, PhDb, Henrik Jönsson, MD, PhDa,*

a Department of Cardiothoracic Surgery, Center for Heart and Lung Disease, Lund University Hospital, Lund, Sweden
b Department of Electrical Measurements, Faculty of Engineering, LTH, Lund University, Lund, Sweden

Accepted for publication December 26, 2007.

* Address correspondence to Dr Jönsson, Department of Cardiothoracic Surgery, Lund University Hospital, SE-221 85 Lund, Sweden (Email: henrik.jonsson{at}med.lu.se).


Dr Petersson discloses that he has a financial relationship with ErySave AB.

 

    Abstract
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Background: Shed mediastinal blood is known to be a source of microemboli in cardiac surgery. The aim of this study was to characterize in detail the lipid particles found in this blood.

Methods: Blood samples were collected from 24 patients undergoing routine cardiac surgery with cardiopulmonary bypass. Arterial and shed blood was analyzed using the Coulter counter technique to establish the number and size of particles. The composition of these lipid particles was compared with that of adipose tissue from the mediastinum using gas chromatography. Scanning electron microscopy was used to visualize the lipid particles in samples of shed blood.

Results: Lipid particles in the size range of 10 to 60 µm were characterized in shed mediastinal blood, and more than 300,000 particles per milliliter of blood were found. Triglyceride profiles in these lipid particles and in adipose tissue were similar, suggesting that their origin is the mediastinum. Scanning electron microscopy showed spherical formations corresponding in size to the particles counted using the Coulter counter.

Conclusions: During the past decade attention has focused on microembolism in cardiac surgery, and this study has helped define the problem. Different strategies, such as eliminating the use of shed mediastinal blood or purifying the blood by different techniques, may improve the results of cardiac surgery in the future.

In cardiac surgery with cardiopulmonary bypass (CPB), retransfusion of shed mediastinal blood is common practice to minimize the blood loss. It has been shown that this blood is contaminated with lipids, which may act as emboli [1]. Furthermore, these particles pass through the CPB circuit and find their way into various organs [2].

In the search for the pathogenesis of CPB-derived brain damage, Moody and colleagues [3–6] documented the presence of small capillary and arteriolar dilatations in autopsy specimens from patients who had undergone cardiac surgery with CPB, and it was later confirmed that these small capillary and arteriolar dilatations were traces of lipid deposition in the brain capillaries.

In a recent porcine study with radioactively tagged lipids, it was shown that these emboli not only find their way into the brain but also, in vast numbers, into the liver, the kidneys, and the heart [2]. Although it is understandable that the retransfusion of shed mediastinal blood containing lipid material will form emboli in several organs, little is known about the nature and physical properties of these lipid particles as they occur in shed blood.

Previously, authors have found lipid particles with light microscopy in CPB [7, 8]. Despite the lack of detailed knowledge about these particles, they continue to be the subject of lively debate. Several techniques have been proposed to avoid them. Some surgeons discard the shed mediastinal blood altogether to eliminate the potential embolic load. A number of new techniques are in use or are emerging. For example, closed-circuit CPB and cell-saving devices are already in use [9], and particle separation by ultrasound (PARSUS) and sedimentation-based separation are under development [10–12].

The aims of this study were to confirm the existence of these particles in human blood and to characterize them thoroughly using various techniques.


    Material and Methods
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Study Design
After approval by the local ethics committee and written information, 24 patients undergoing routine elective cardiac surgery with CPB were included in the study. In each case, 10 mL of shed mediastinal blood was collected from the pericardium after the administration of heparin and after aortic cannulation, but before the initiation of CPB. At the same time, 10 mL of the patient’s arterial blood was drawn from a peripheral arterial line. An additional 5 mL of shed mediastinal blood and a sample of mediastinal adipose tissue were taken from the first 9 patients for comparative analysis by gas chromatography. Coulter counter analysis was performed immediately, whereas the samples taken for gas chromatography were frozen for later analysis. Complete Coulter counter data were achieved in 16 patients in both centrifuged and noncentrifuged series and are presented.

Coulter Counter Analysis
A Multisizer 3 Beckman Coulter counter with a 100-µm aperture probe (Beckman Coulter Inc, Fullerton, CA) was used for particle size determination [13]. The narrow aperture between the electrodes constitutes the sensing zone through which suspended particles pass. In the sensing zone each particle displaces its own volume of electrolyte. The volume displaced is recorded as a voltage pulse, the height of each pulse being proportional to the volume of the particle. The device was programmed to count and determine the size of all particles with diameters between 2 and 60 µm, at 0.2-µm intervals.

All blood samples were divided into two separate aliquots of 7 and 3 mL. The 7-mL aliquot was centrifuged at 4,200 rpm for 45 minutes to separate lipid material from blood cells. Twenty microliters of the supernatant was diluted with 100 mL of saline solution, and was used for analysis in the Coulter counter. In the protocol used, particles were counted for 100 seconds. From the 3-mL aliquot of noncentrifuged blood, 1 µL of blood was diluted with 100 mL of saline solution. A fixed volume of 10 mL was then analyzed in the Coulter counter.

Gas Chromatography
Gas chromatography was performed on mediastinal adipose tissue and the supernatant of shed blood from the first 9 patients. The samples were prepared in a three-step process including extraction, lipid fractioning, and transesterification [14, 15]. Neutral lipids and phospholipids were then analyzed separately using a Hewlett-Packard HP-5 column in a Hewlett-Packard 6890 gas chromatograph (both supplied by Agilent Technologies Sweden AB, Kista Sweden).

Scanning Electron Microscopy
Supernatant from shed blood was mixed with a 1% solution of OsO4 (Link Nordic, Stockholm, Sweden), which was dissolved in 0.1 mol/L Sörensen buffer at 7.2 pH. It was placed on a SuperFrost glass slide (Menzel-Gläser, Braunschweig, Germany) to allow for sedimentation. The samples were then dried and transferred to buttons for scanning electron microscopy. The samples were covered with a 15-nm layer of gold in a Polaron E5150 scanning electron microscopy coating unit (Quorum Technologies Ltd, East Sussex, UK). Scanning electron microscopy was performed with a Philips 515 scanning electron microscope (Philips, Amsterdam, The Netherlands).

Data Analysis
All data are presented as mean ± one standard deviation unless otherwise stated. To determine the lipid particle content in whole (noncentrifuged) blood, subtraction analysis was performed. First, normal particle or cell content of blood from the arterial line was determined for each patient using Coulter counter analysis. The same analysis was then performed on the shed mediastinal blood. The number of particles not normally occurring in arterial blood was determined by subtracting the background level (arterial blood) from that in shed blood. The final result was corrected for the difference in hematocrit in the samples. Particles were grouped in size ranges of 5 µm to determine the distribution of particle sizes in noncentrifuged blood. Particles smaller than 10 µm were excluded to avoid interference from any remaining blood cells.


    Results
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Coulter counter analysis of centrifuged shed mediastinal blood showed much higher levels of particles in the range of 10 to 60 µm than in centrifuged arterial catheter blood (Fig 1). The highest number of particles had sizes around 10 µm and the amount decreased steadily to 60 µm.


Figure 1
View larger version (16K):
[in this window]
[in a new window]

 
Fig 1. Relative size distribution of particles found in the supernatant (after centrifugation) of arterial (lower curve) and shed mediastinal blood (upper curve).

 
A similar pattern regarding size and distribution was observed in noncentrifuged blood after subtraction analysis (Fig 2). The subtraction analysis also provided the number of particles per milliliter of shed blood: 361,468 ± 699,678 in the range 10 to 60 µm, 96,963 ± 140,317 in the range 15 to 60 µm, and 33,137 ± 55,808 in the range 20 to 60 µm (Fig 3).


Figure 2
View larger version (11K):
[in this window]
[in a new window]

 
Fig 2. Size distribution of particles in whole shed mediastinal blood. Size distribution was calculated by subtracting the number of particles the arterial line blood from the number of particles in shed mediastinal blood.

 

Figure 3
View larger version (12K):
[in this window]
[in a new window]

 
Fig 3. Number of particles found in each milliliter of shed blood grouped in different size ranges.

 
Gas chromatography revealed a pattern of triglycerides in the supernatant of shed blood similar to that found in mediastinal adipose tissue (Table 1). Scanning electron microscopy showed a variation in size and a spherical appearance of the lipid emboli in centrifuged shed blood (Fig 4).


View this table:
[in this window]
[in a new window]

 
Table 1 Triglyceride Profile a
 

Figure 4
View larger version (128K):
[in this window]
[in a new window]

 
Fig 4. Scanning electron microscopy images of particles in the supernatant of shed blood. The scale indicates 20-µm intervals, yielding 100 µm for the bar.

 

    Comment
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
The findings of this study show that there are considerable numbers of particles larger than 10 µm in shed mediastinal blood. These particles are in the size range that can pass through standard filters in a CPB circuit, but are larger than the diameter of arteriolar vessels.

When using cardiotomy suction, these lipid particles are introduced into the CPB circuit and present an immediate embolic threat to patients undergoing open heart surgery. In a porcine model, it was shown that lipid particles entered the circulation and found their way into several organs [2]. Emboli in this size range have been found in the brains of dogs in an experimental model [1], and in patients who died several years after cardiac surgery [5, 16]. Even though this study did not investigate the route of the particles through the CPB circuit, it is likely that they would pass the circuit and end up as embolic material in different organs.

When lipids are added to a hydrophilic liquid such as blood, they do not dissolve but remain in suspension. For lipids to dissolve in water or blood, emulsifiers and energy must be added. We did not determine whether the particles were emulsified or not. However, the finding of separate particles in both Coulter counter analysis and electron microscopy indicates that the particles were in fact emulsified. A vast number of agents normally found in blood can serve as emulsifiers (eg, circulating albumin, and phospholipids derived from cell membranes and membranes from naturally occurring lipids). In addition, hemolysis in blood passing through the CPB circuit provides an abundant source of cell membranes (phospholipids) that can act as emulsifiers. Whether lipid particles are emulsified or not can play an important role in the interaction with the CPB circuit, as most of the surfaces are hydrophobic, eg, polyvinylchloride, silicone tubing, polyethylene, and microporous polypropylene, in the filtering system and oxygenator. Hydrophilic particles, such as blood cells and emulsified lipids, will thus not adhere to the surfaces in the CPB circuit, but pass freely into the circulation.

The Coulter counter analysis is a novel method of measuring particles in blood during cardiac surgery. The method is well established in the accurate determination of particles such as microspheres, blood cells, bacteria, and cells from cell cultures [13, 17]. In this study we were able to count tens of thousands of particles in each sample quickly and accurately. Moreover, the device also determines the volume of each particle.

When introducing new analysis techniques, sample preparation may alter the original composition, leading to erroneous or unrepresentative results. Sample centrifugation is a potential source of error, because strong forces are applied to biologic matter, which may alter its structure. However, the subtraction analysis of noncentrifuged blood revealed a similar pattern of size distribution for particles larger than 10 µm as compared with centrifuged shed blood (Figs 1, 2). It is therefore probable that the centrifugation process did not affect the size distribution of lipid particles in the suspension. Scanning electron microscopy clearly showed spherical particles in the same size range as found using the Coulter counter (Fig 4). Substances added to the samples before analysis could also lead to errors. In this study we only added saline solution at room temperature, which is unlikely to affect the composition of the particles. Based on our experience, the Coulter counter seems to be a reliable and robust method of determining the size and number of lipid particles in blood.

Gas chromatography was used to determine the lipid composition in the supernatant of shed blood and in adipose tissue from the mediastinum. Similar patterns were found. However, this analysis was not corrected for other lipids, such as endogenous lipids and the anesthetic agent propofol. Correction for these lipids could affect the results. Gas chromatography should therefore only be used to provide an indication of the potential source of these lipids.

We did not address the possible clinical effect of the emboli on the patients in this study. We have, however, learned that each milliliter of shed blood can contain hundreds of thousands of lipid particles. Other authors have shown that lipid material will end up as emboli in various organs throughout the body [1, 2, 5]. It is thus reasonable to assume that retransfusing shed mediastinal blood will cause organ damage. Two recent studies using cell-saving devices to wash mediastinal blood have shown conflicting results on neuropsychological outcome [18, 19]. One study showed a clear reduction on the incidence of cognitive decline, whereas the other reported none. With this combined knowledge, it is difficult to ignore these particles and the threat they may pose to the patient.

A novel technique has been used to characterize lipid particles in shed blood, which has opened new opportunities in embolism research. In addition, we have highlighted the need for further research into the potential threat of these particles to patients undergoing cardiac surgery.


    References
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 

  1. Brooker RF, Brown WR, Moody DM, et al. Cardiotomy suction: a major source of brain lipid emboli during cardiopulmonary bypass Ann Thorac Surg 1998;65:1651-1655.[Abstract/Free Full Text]
  2. Bronden B, Dencker M, Allers M, Plaza I, Jonsson H. Differential distribution of lipid microemboli after cardiac surgery Ann Thorac Surg 2006;81:643-648.[Abstract/Free Full Text]
  3. Brown WR, Moody DM, Challa VR. Cerebral fat embolism from cardiopulmonary bypass J Neuropathol Exp Neurol 1999;58:109-119.[Medline]
  4. Challa VR, Moody DM, Troost BT. Brain embolic phenomena associated with cardiopulmonary bypass J Neurol Sci 1993;117:224-231.[Medline]
  5. Moody DM, Brown WR, Challa VR, et al. Brain microemboli associated with cardiopulmonary bypass: a histologic and magnetic resonance imaging study Ann Thorac Surg 1995;59:1304-1307.[Abstract/Free Full Text]
  6. Moody DM, Bell MA, Challa VR, Johnston WE, Prough DS. Brain microemboli during cardiac surgery or aortography Ann Neurol 1990;28:477-486.[Medline]
  7. Kaza AK, Cope JT, Fiser SM, et al. Elimination of fat microemboli during cardiopulmonary bypass Ann Thorac Surg 2003;75:555-559.[Abstract/Free Full Text]
  8. Lee Jr WH, Krumhaar D, Fonkalsrud EW, Schjeide OA, Maloney Jr JV. Denaturation of plasma proteins as a cause of morbidity and death after intracardiac operations Surgery 1961;50:29-39.[Medline]
  9. Kincaid EH, Jones TJ, Stump DA, et al. Processing scavenged blood with a cell saver reduces cerebral lipid microembolization Ann Thorac Surg 2000;70:1296-1300.[Abstract/Free Full Text]
  10. Engstrom KG, Appelblad M. Fat reduction in pericardial suction blood by spontaneous density separation: an experimental model on human liquid fat versus soya oil Perfusion 2003;18:39-45.[Abstract/Free Full Text]
  11. Jonsson H, Holm C, Nilsson A, et al. Particle separation using ultrasound can radically reduce embolic load to brain after cardiac surgery Ann Thorac Surg 2004;78:1572-1577.[Abstract/Free Full Text]
  12. Petersson F, Nilsson A, Holm C, Jonsson H, Laurell T. Separation of lipids from blood utilizing ultrasonic standing waves in microfluidic channels Analyst 2004;129:938-943.[Medline]
  13. Kimelberg HK, O’Connor ER, Sankar P, Keese C. Methods for determination of cell volume in tissue culture Can J Physiol Pharmacol 1992;70(Suppl):S323-S333.[Medline]
  14. Dobbs FC, Findlay RH. Analysis of microbial lipids to determine biomass and detect the response of sedimentary microorganisms to disturbanceIn: Kemp PF, editor. Handbook of methods in aquatic microbial ecology. Boca Raton: Lewis Publishers; 1993. pp. 347-358.
  15. Findlay RH, Dobbs FC. Quantitative description of microbial communities using lipid analysisIn: Kemp PF, editor. Handbook of methods in aquatic microbial ecology. Boca Raton: Lewis Publishers; 1993. pp. 777.
  16. Brown WR, Moody DM, Challa VR, Stump DA, Hammon JW. Longer duration of cardiopulmonary bypass is associated with greater numbers of cerebral microemboli Stroke 2000;31:707-713.[Abstract/Free Full Text]
  17. Kubitschek HE, Friske JA. Determination of bacterial cell volume with the Coulter counter J Bacteriol 1986;168:1466-1467.[Abstract/Free Full Text]
  18. Rubens FD, Boodhwani M, Mesana T, et al. The cardiotomy trial: a randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function Circulation 2007;116:I-89-I-97.[Medline]
  19. Djaiani G, Fedorko L, Borger MA, et al. Continuous-flow cell saver reduces cognitive decline in elderly patients after coronary bypass surgery Circulation 2007;116:1888-1895.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
ICVTSHome page
H. Jonsson, A. Eyjolfsson, S. Scicluna, P. Paulsson, and P. Johnsson
Circulating particles during cardiac surgery
Interactive CardioVascular and Thoracic Surgery, May 1, 2009; 8(5): 538 - 542.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Atli Eyjolfsson
Per Johnsson
Henrik Jönsson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eyjolfsson, A.
Right arrow Articles by Jönsson, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eyjolfsson, A.
Right arrow Articles by Jönsson, H.
Related Collections
Right arrow Extracorporeal circulation


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS